BACKGROUND The World Health Organization recommends the use of computer-aided detection (CAD) in conjunction with chest X-rays (CXR) for tuberculosis (TB) screening and triaging in i...
Briend A, Myatt M, Berkley JA, Black RE, Boyd EM, et al.
2023-06-01 • Public Health Nutrition
2023-06-01 • Public Health Nutrition
OBJECTIVE To compare the prognostic value of mid-upper arm circumference (MUAC), weight-for-height Z-score (WHZ) and weight-for-age Z-score (WAZ) for predicting death over periods of...
Khara T, Myatt M, Sadler K, Bahwere P, Berkley JA, et al.
2023-02-03 • Public Health Nutrition
2023-02-03 • Public Health Nutrition
OBJECTIVE To understand which anthropometric diagnostic criteria best discriminate higher from lower risk of death in children and explore programme implications.
Ali E, Ferir MC, Reid AJ, Gray H, van den Boogaard W, et al.
2016-12-15 • Disaster Medicine and Public Health Preparedness
2016-12-15 • Disaster Medicine and Public Health Preparedness
OBJECTIVES Typhoon Haiyan hit the Philippines in November 2013 and left a trail of destruction. As part of its emergency response, Médecins Sans Frontières distributed materials for ...
Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al.
2011-04-19 • Lancet
2011-04-19 • Lancet
BACKGROUND: The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in controlled studies...
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bayona J, et al.
2012-08-28 • PLOS Medicine
2012-08-28 • PLOS Medicine
Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the ...
Sepsis is one of the leading causes of childhood mortality, yet controversy surrounds the current treatment approach. We conducted a systematic review to assess the evidence base for flu...
Sweeney S, Berry C, Kazounis E, Motta I, Vassall A, et al.
2022-12-07 • PLOS Global Public Health
2022-12-07 • PLOS Global Public Health
Current options for treating tuberculosis (TB) that is resistant to rifampicin (RR-TB) are few, and regimens are often long and poorly tolerated. Following recent evidence from the TB-PR...
Chandna A, Aderie EM, Ahmad R, Arguni E, Ashley EA, et al.
2021-01-25 • BMJ Open
2021-01-25 • BMJ Open
INTRODUCTION In rural and difficult-to-access settings, early and accurate recognition of febrile children at risk of progressing to serious illness could contribute to improved pati...
Trudeau MO, Baron E, Herard P, Labar AS, Lassalle X, et al.
2015-08-12 • Journal of the American Medical Association (JAMA)
2015-08-12 • Journal of the American Medical Association (JAMA)
IMPORTANCE Little is known about the scope of practice and outcomes in pediatric surgery performed by humanitarian organizations in resource-poor settings and conflict zones. This st...
2012-12-04 • International Journal of Tuberculosis and Lung Disease
2012-12-04 • International Journal of Tuberculosis and Lung Disease
BACKGROUND: Scaling up treatment for multidrug-resistant tuberculosis is a global health priority. However, current treatment regimens are long and associated with side effects, and defa...
Cox V, Brigden G, Crespo RH, Lessem E, Lynch S, et al.
2018-04-01 • International Journal of Tuberculosis and Lung Disease
2018-04-01 • International Journal of Tuberculosis and Lung Disease
SETTING The World Health Organization recommended two new drugs, bedaquiline (BDQ) and delamanid (DLM), for the treatment of multidrug-resistant tuberculosis (MDR-TB) in 2013 and 201...
Weintraub AC, Garcia MG, Birri E, Severy N, Ferir MC, et al.
2016-09-12 • International Health
2016-09-12 • International Health
BACKGROUND Severe mental disorders are often neglected following a disaster. Based on Médecins Sans Frontières' (MSF) experience of providing mental health (MH) care after the 2013 t...
Sweeney S, Berry C, Kazounis E, Motta I, Vassall A, et al.
2022-11-10 • medRxiv
2022-11-10 • medRxiv
INTRODUCTION Current options for treating tuberculosis (TB) that is resistant to rifampicin (RR-TB) are few, and regimens are often long and poorly tolerated. Following recent eviden...
